+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
INDRAMEDCO

Indraprastha Medical Corporation Share Price

₹310.65 +5 (1.64%)
51.53% Fall from 52W High

02 Nov, 2026 3:31 PM (IST)

Indraprastha Medical Corporation live price: ₹310.65. It opened at ₹307 vs previous close ₹306; intraday high/low: ₹317/₹304. The 50 & 200 DMA stand at ₹338.40/₹379.60.

Indraprastha Medical Corporation Performance

  • Today's Low
  • ₹304
  • Today's High
  • ₹317
  • 52 Week Low
  • ₹294
  • 52 Week High
  • ₹641
  • Open Price₹307
  • Previous Close₹306
  • Volume120,276
  • 50 DMA₹338.40
  • 100 DMA₹356.30
  • 200 DMA₹379.60

Indraprastha Medical Corporation Chart

Investment Returns

  • Over 1 Month -8.25%
  • Over 3 Month -15.2%
  • Over 6 Month -22.73%
  • Over 1 Year -48.78%

Smart Investing Starts Here Start SIP with Indraprastha Medical Corporation for Steady Growth!

Invest Now

Indraprastha Medical Corporation Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 14.8
  • PEG Ratio
  • 1.5
  • Market Cap Cr
  • 2,848
  • P/B Ratio
  • 3.6
  • Average True Range
  • 10.6
  • EPS
  • 21
  • Dividend Yield
  • 1.3
  • MACD Signal
  • -10.9
  • RSI
  • 39.19
  • MFI
  • 23.2

Latest Stock News Updates

Indraprastha Medical Corporation Ltd - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication

We hereby submit copies of the public notice of the financial results published on 30th October 2026, in the Financial Express all India edition in English language and in Jansatta Delhi edition in Hindi language.

Q2FY27 Quarterly Result Announced for Indraprastha Medical Corporation Ltd.

<h3><span style="font-size:16px;"><strong>Healthcare Facilities company Indraprastha Medical Corporation announced Q2FY27 results</strong></span></h3> <p><strong>Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIChAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="Whbk3b_1l"> <li data-complete="true" data-hveid="CAAIChAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="Whbk3b_1m"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="Whbk3b_1o">Revenue from operations<!--TgQPHd|||[]--></strong> stood at Rs 412.85 crore in Q2FY27, showing a QoQ growth of 1.65% over Rs 406.15 crore in Q1FY27 and a YoY growth of 8.35% over Rs 381.03 crore in Q2FY26. For H1FY27, revenue from operations registered at Rs 819.00 crore, showing an increase of 9.77% compared to Rs 746.09 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAE" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="Whbk3b_1u"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="Whbk3b_1w">Total income<!--TgQPHd|||[]--></strong> reached Rs 421.40 crore in Q2FY27, indicating a QoQ increase of 1.65% relative to Rs 414.57 crore in Q1FY27 and a YoY growth of 8.50% compared to Rs 388.40 crore in Q2FY26. For H1FY27, total income stood at Rs 835.97 crore, showing a 9.94% expansion versus Rs 760.36 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAH" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="Whbk3b_22"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="Whbk3b_24">Profit Before Tax (PBT)<!--TgQPHd|||[]--></strong> logged at Rs 72.07 crore in Q2FY27, representing a QoQ drop of 3.67% from Rs 74.82 crore in Q1FY27 but showing a YoY increase of 8.69% against Rs 66.31 crore in Q2FY26. For H1FY27, PBT was recorded at Rs 146.89 crore, reflecting a 9.11% expansion over Rs 134.62 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAK" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="Whbk3b_2a"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="Whbk3b_2c">Profit for the period after tax (PAT)<!--TgQPHd|||[]--></strong> came in at Rs 53.58 crore in Q2FY27, facing a QoQ reduction of 3.63% from Rs 55.60 crore in Q1FY27 but increasing 8.33% YoY over Rs 49.46 crore in Q2FY26. For H1FY27, PAT registered at Rs 109.43 crore, gaining 8.43% YoY versus Rs 100.92 crore in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIChAN" data-processed="true" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="Whbk3b_2i"><strong data-complete="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="tP2kf#s32ZS" jsuid="Whbk3b_2k">Earnings Per Share (EPS)<!--TgQPHd|||[]--></strong> stood at basic and diluted values of Rs 5.84 in Q2FY27, indicating a QoQ decline of 4.11% compared to Rs 6.09 in Q1FY27, but climbing 8.15% YoY against Rs 5.40 in Q2FY26. For H1FY27, EPS expanded by 8.45% YoY to Rs 11.94, compared to Rs 11.01 in H1FY26.</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5917006/" target="_blank">Result PDF</a></p>

Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Outcome for Outcome Of Board Meeting- Un-Audited Financial Results For The Quarter Ended 30-09-2026

We are enclosing herewith the Un-audited Financial Results for the quarter and half yearly ended 30th September 2026, along with a copy of the Limited Review Report by the Statutory Auditors of the Company.

Indraprastha Medical Corporation Financials

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
₹310.65
+ 5 (1.64%)
pointer
  • Bearish Moving Average 14
  • Bullish Moving Average 2
  • 20 Day
  • ₹320.20
  • 50 Day
  • ₹338.40
  • 100 Day
  • ₹356.30
  • 200 Day
  • ₹379.60

Resistance and Support

310.52 Pivot Speed
  • R3 331.10
  • R2 324.20
  • R1 317.40
  • S1 303.80
  • S2 296.90
  • S3 290.10

Indraprastha Medical Corporation Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-29 Quarterly Results
2026-08-06 Quarterly Results
2026-05-12 Audited Results & Final Dividend
2026-02-03 Quarterly Results
2025-11-01 Quarterly Results
Date Purpose Remarks
2026-09-18 FINAL Rs.4.00 per share(40%)Final Dividend
2025-09-18 FINAL Rs.4.50 per share(45%)Final Dividend
View Indraprastha Medical Corporation Dividend History Arrow

Indraprastha Medical Corporation Shareholding Pattern

51%
44.83%
2.39%
0.91%
0.86%

About Indraprastha Medical Corporation

Indraprastha Medical Corporation operates the flagship Indraprastha Apollo Hospitals and is a prominent public-private partnership healthcare provider in India. View More
  • NSE Symbol
  • INDRAMEDCO
  • BSE Symbol
  • 532150
  • ISIN
  • INE681B01017

Similar Stocks to Indraprastha Medical Corporation

Indraprastha Medical Corporation FAQs

Indraprastha Medical Corporation share price is ₹310 As on 03 November, 2026 | 00:28

The Market Cap of Indraprastha Medical Corporation is ₹2847.8 Cr As on 03 November, 2026 | 00:28

The P/E ratio of Indraprastha Medical Corporation is 14.8 As on 03 November, 2026 | 00:28

The PB ratio of Indraprastha Medical Corporation is 3.6 As on 03 November, 2026 | 00:28

The 52 week High & Low of Indraprastha Medical Corporation is ₹640.8/₹293.6 respectively As on 03 November, 2026 | 00:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23